Effect of polyherbal formulation on experimental models of inflammatory bowel diseases
- PMID: 15013181
- DOI: 10.1016/j.jep.2003.09.042
Effect of polyherbal formulation on experimental models of inflammatory bowel diseases
Abstract
A polyherbal ayurvedic formulation from an ancient authentic classical text of ayurveda was evaluated for its activity against inflammatory bowel disease (IBD). The polyherbal formulation contained four different drugs viz., Bilwa (Aegle marmeloes), Dhanyak (Coriandrum sativum), Musta (Cyperus rotundus) and Vala (Vetiveria zinzanioids). The formulation has been tried before in clinical practice and was found to be useful in certain number of cases of IBD (ulcerative colitis), so was tried in the same form i.e., decoction (aqueous extract) in experimental animals to revalidate the claims of the same. The formulation was tried on two different experimental animal models of inflammatory bowel disease, which are acetic acid-induced colitis in mice and indomethacin-induced enterocolitis in rats. Prednisolone was used as the standard drug for comparison. The formulation showed significant inhibitory activity against inflammatory bowel disease induced in these experimental animal models. The activity was comparable with the standard drug prednisolone. The results obtained established the efficacy of this polyherbal formulation against inflammatory bowel diseases.
Similar articles
-
Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.Indian J Exp Biol. 2011 May;49(5):343-51. Indian J Exp Biol. 2011. PMID: 21615058
-
Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis.Int J Tissue React. 2004;26(1-2):43-51. Int J Tissue React. 2004. PMID: 15573692
-
Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis.Inflammopharmacology. 2004;12(2):131-52. doi: 10.1163/1568560041352301. Inflammopharmacology. 2004. PMID: 15265316
-
Experimental models of inflammatory bowel disease.Arch Immunol Ther Exp (Warsz). 2003;51(3):149-55. Arch Immunol Ther Exp (Warsz). 2003. PMID: 12894869 Review.
-
Mouse models of inflammatory bowel disease.Curr Opin Drug Discov Devel. 2006 Mar;9(2):207-17. Curr Opin Drug Discov Devel. 2006. PMID: 16566291 Review.
Cited by
-
The Dawn till Dusk of phytopharmaceuticals.Saudi Pharm J. 2024 Nov;32(11):102185. doi: 10.1016/j.jsps.2024.102185. Epub 2024 Oct 2. Saudi Pharm J. 2024. PMID: 39435370 Free PMC article. Review.
-
Evaluation of the protective effect of Pterocarpus marsupium on acetic acid-induced ulcerative colitis in rats.Inflammopharmacology. 2015 Aug;23(4):195-201. doi: 10.1007/s10787-015-0234-3. Epub 2015 May 20. Inflammopharmacology. 2015. PMID: 25991550
-
Casuarina glauca branchlets' extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies.Front Pharmacol. 2023 Dec 22;14:1322181. doi: 10.3389/fphar.2023.1322181. eCollection 2023. Front Pharmacol. 2023. PMID: 38196993 Free PMC article.
-
Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease.BMC Complement Altern Med. 2011 Apr 28;11:34. doi: 10.1186/1472-6882-11-34. BMC Complement Altern Med. 2011. PMID: 21527003 Free PMC article.
-
Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats.Res Pharm Sci. 2011 Jan;6(1):13-21. Res Pharm Sci. 2011. PMID: 22049274 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources